Logo image of DAN

DANA INC (DAN) Stock Fundamental Analysis

NYSE:DAN - New York Stock Exchange, Inc. - US2358252052 - Common Stock - Currency: USD

16.85  -0.4 (-2.32%)

After market: 16.85 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to DAN. DAN was compared to 80 industry peers in the Automobile Components industry. DAN has a bad profitability rating. Also its financial health evaluation is rather negative. DAN has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

DAN had positive earnings in the past year.
In the past year DAN had a positive cash flow from operations.
In multiple years DAN reported negative net income over the last 5 years.
Each year in the past 5 years DAN had a positive operating cash flow.
DAN Yearly Net Income VS EBIT VS OCF VS FCFDAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

1.2 Ratios

DAN has a worse Return On Assets (-0.45%) than 75.00% of its industry peers.
DAN has a Return On Equity of -2.54%. This is in the lower half of the industry: DAN underperforms 73.75% of its industry peers.
DAN has a Return On Invested Capital of 4.95%. This is in the lower half of the industry: DAN underperforms 78.75% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for DAN is below the industry average of 9.12%.
Industry RankSector Rank
ROA -0.45%
ROE -2.54%
ROIC 4.95%
ROA(3y)-1.18%
ROA(5y)-0.27%
ROE(3y)-5.82%
ROE(5y)-1.8%
ROIC(3y)5.02%
ROIC(5y)4.73%
DAN Yearly ROA, ROE, ROICDAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

DAN has a Operating Margin of 3.23%. This is in the lower half of the industry: DAN underperforms 78.75% of its industry peers.
DAN's Operating Margin has declined in the last couple of years.
DAN has a Gross Margin of 8.61%. This is amonst the worse of the industry: DAN underperforms 88.75% of its industry peers.
DAN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.23%
PM (TTM) N/A
GM 8.61%
OM growth 3Y-8.06%
OM growth 5Y-14.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-8.28%
DAN Yearly Profit, Operating, Gross MarginsDAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DAN is destroying value.
Compared to 1 year ago, DAN has more shares outstanding
The number of shares outstanding for DAN has been increased compared to 5 years ago.
DAN has a worse debt/assets ratio than last year.
DAN Yearly Shares OutstandingDAN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
DAN Yearly Total Debt VS Total AssetsDAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

DAN has an Altman-Z score of 1.86. This is not the best score and indicates that DAN is in the grey zone with still only limited risk for bankruptcy at the moment.
DAN has a Altman-Z score of 1.86. This is in the lower half of the industry: DAN underperforms 77.50% of its industry peers.
DAN has a debt to FCF ratio of 21.33. This is a negative value and a sign of low solvency as DAN would need 21.33 years to pay back of all of its debts.
The Debt to FCF ratio of DAN (21.33) is worse than 75.00% of its industry peers.
DAN has a Debt/Equity ratio of 1.85. This is a high value indicating a heavy dependency on external financing.
DAN has a Debt to Equity ratio of 1.85. This is amonst the worse of the industry: DAN underperforms 91.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.85
Debt/FCF 21.33
Altman-Z 1.86
ROIC/WACC0.54
WACC9.22%
DAN Yearly LT Debt VS Equity VS FCFDAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 1.43 indicates that DAN should not have too much problems paying its short term obligations.
DAN has a worse Current ratio (1.43) than 83.75% of its industry peers.
DAN has a Quick Ratio of 1.43. This is a bad value and indicates that DAN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of DAN (0.85) is worse than 86.25% of its industry peers.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 0.85
DAN Yearly Current Assets VS Current LiabilitesDAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

3

3. Growth

3.1 Past

DAN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
DAN shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -21.71% yearly.
The Revenue has decreased by -7.00% in the past year.
Measured over the past years, DAN shows a small growth in Revenue. The Revenue has been growing by 3.59% on average per year.
EPS 1Y (TTM)0%
EPS 3Y-18.46%
EPS 5Y-21.71%
EPS Q2Q%-40.91%
Revenue 1Y (TTM)-7%
Revenue growth 3Y4.76%
Revenue growth 5Y3.59%
Sales Q2Q%-14%

3.2 Future

Based on estimates for the next years, DAN will show a very strong growth in Earnings Per Share. The EPS will grow by 28.77% on average per year.
DAN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.50% yearly.
EPS Next Y52.78%
EPS Next 2Y46.46%
EPS Next 3Y35.32%
EPS Next 5Y28.77%
Revenue Next Year-5.95%
Revenue Next 2Y-2.72%
Revenue Next 3Y-1.07%
Revenue Next 5Y1.5%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DAN Yearly Revenue VS EstimatesDAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
DAN Yearly EPS VS EstimatesDAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

DAN is valuated rather expensively with a Price/Earnings ratio of 20.80.
DAN's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.30, DAN is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 8.73, the valuation of DAN can be described as reasonable.
DAN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. DAN is cheaper than 62.50% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, DAN is valued rather cheaply.
Industry RankSector Rank
PE 20.8
Fwd PE 8.73
DAN Price Earnings VS Forward Price EarningsDAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DAN is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DAN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 18.89
EV/EBITDA 6.31
DAN Per share dataDAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

DAN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as DAN's earnings are expected to grow with 35.32% in the coming years.
PEG (NY)0.39
PEG (5Y)N/A
EPS Next 2Y46.46%
EPS Next 3Y35.32%

3

5. Dividend

5.1 Amount

DAN has a Yearly Dividend Yield of 2.32%.
Compared to an average industry Dividend Yield of 4.30, DAN has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.37, DAN has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.32%

5.2 History

The dividend of DAN decreases each year by -0.02%.
DAN has paid a dividend for at least 10 years, which is a reliable track record.
DAN has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-0.02%
Div Incr Years0
Div Non Decr Years4
DAN Yearly Dividends per shareDAN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

The earnings of DAN are negative and hence is the payout ratio. DAN will probably not be able to sustain this dividend level.
DP-165.71%
EPS Next 2Y46.46%
EPS Next 3Y35.32%
DAN Yearly Income VS Free CF VS DividendDAN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

DANA INC

NYSE:DAN (7/11/2025, 8:04:00 PM)

After market: 16.85 0 (0%)

16.85

-0.4 (-2.32%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)07-30 2025-07-30/amc
Inst Owners106.72%
Inst Owner Change-0.01%
Ins Owners0.44%
Ins Owner Change9.2%
Market Cap2.46B
Analysts73.85
Price Target22.1 (31.16%)
Short Float %4.17%
Short Ratio3.07
Dividend
Industry RankSector Rank
Dividend Yield 2.32%
Yearly Dividend0.4
Dividend Growth(5Y)-0.02%
DP-165.71%
Div Incr Years0
Div Non Decr Years4
Ex-Date05-09 2025-05-09 (0.1)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)51.52%
Min EPS beat(2)-21.99%
Max EPS beat(2)125.02%
EPS beat(4)2
Avg EPS beat(4)16.62%
Min EPS beat(4)-47.77%
Max EPS beat(4)125.02%
EPS beat(8)5
Avg EPS beat(8)36.01%
EPS beat(12)7
Avg EPS beat(12)19.66%
EPS beat(16)9
Avg EPS beat(16)10.37%
Revenue beat(2)1
Avg Revenue beat(2)0.22%
Min Revenue beat(2)-0.89%
Max Revenue beat(2)1.34%
Revenue beat(4)1
Avg Revenue beat(4)-1.7%
Min Revenue beat(4)-5.02%
Max Revenue beat(4)1.34%
Revenue beat(8)2
Avg Revenue beat(8)-1.62%
Revenue beat(12)6
Avg Revenue beat(12)-0.43%
Revenue beat(16)10
Avg Revenue beat(16)1.07%
PT rev (1m)18.18%
PT rev (3m)8.33%
EPS NQ rev (1m)1.06%
EPS NQ rev (3m)-6.01%
EPS NY rev (1m)3.66%
EPS NY rev (3m)-9.41%
Revenue NQ rev (1m)-0.12%
Revenue NQ rev (3m)1.67%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)0.42%
Valuation
Industry RankSector Rank
PE 20.8
Fwd PE 8.73
P/S 0.25
P/FCF 18.89
P/OCF 4.77
P/B 1.78
P/tB 2.52
EV/EBITDA 6.31
EPS(TTM)0.81
EY4.81%
EPS(NY)1.93
Fwd EY11.46%
FCF(TTM)0.89
FCFY5.29%
OCF(TTM)3.53
OCFY20.97%
SpS67.94
BVpS9.46
TBVpS6.68
PEG (NY)0.39
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.45%
ROE -2.54%
ROCE 6.44%
ROIC 4.95%
ROICexc 5.5%
ROICexgc 6.03%
OM 3.23%
PM (TTM) N/A
GM 8.61%
FCFM 1.31%
ROA(3y)-1.18%
ROA(5y)-0.27%
ROE(3y)-5.82%
ROE(5y)-1.8%
ROIC(3y)5.02%
ROIC(5y)4.73%
ROICexc(3y)5.54%
ROICexc(5y)5.19%
ROICexgc(3y)6.12%
ROICexgc(5y)5.83%
ROCE(3y)6.38%
ROCE(5y)6.02%
ROICexcg growth 3Y-0.28%
ROICexcg growth 5Y-11.5%
ROICexc growth 3Y1.52%
ROICexc growth 5Y-10.28%
OM growth 3Y-8.06%
OM growth 5Y-14.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-8.28%
F-Score4
Asset Turnover1.27
Health
Industry RankSector Rank
Debt/Equity 1.85
Debt/FCF 21.33
Debt/EBITDA 3.47
Cap/Depr 92.33%
Cap/Sales 3.89%
Interest Coverage 250
Cash Conversion 69.88%
Profit Quality N/A
Current Ratio 1.43
Quick Ratio 0.85
Altman-Z 1.86
F-Score4
WACC9.22%
ROIC/WACC0.54
Cap/Depr(3y)107.96%
Cap/Depr(5y)101.61%
Cap/Sales(3y)4.26%
Cap/Sales(5y)4.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y-18.46%
EPS 5Y-21.71%
EPS Q2Q%-40.91%
EPS Next Y52.78%
EPS Next 2Y46.46%
EPS Next 3Y35.32%
EPS Next 5Y28.77%
Revenue 1Y (TTM)-7%
Revenue growth 3Y4.76%
Revenue growth 5Y3.59%
Sales Q2Q%-14%
Revenue Next Year-5.95%
Revenue Next 2Y-2.72%
Revenue Next 3Y-1.07%
Revenue Next 5Y1.5%
EBIT growth 1Y-14.89%
EBIT growth 3Y-3.68%
EBIT growth 5Y-11.9%
EBIT Next Year115.65%
EBIT Next 3Y34.36%
EBIT Next 5Y28.72%
FCF growth 1Y-16.67%
FCF growth 3YN/A
FCF growth 5Y-19.8%
OCF growth 1Y-14.17%
OCF growth 3Y41.75%
OCF growth 5Y-6.71%